What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practice.
about
Ustekinumab-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and lupus erythematosus tumidus.Drug survival of biologic treatments in psoriasis: a systematic review.Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients.Clinical factors predicting the therapeutic response to ustekinumab in patients with moderate to severe chronic plaque psoriasis
P2860
What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practice.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
What happened after the clinic ...... ab in daily clinical practice.
@en
What happened after the clinic ...... ab in daily clinical practice.
@nl
type
label
What happened after the clinic ...... ab in daily clinical practice.
@en
What happened after the clinic ...... ab in daily clinical practice.
@nl
prefLabel
What happened after the clinic ...... ab in daily clinical practice.
@en
What happened after the clinic ...... ab in daily clinical practice.
@nl
P2093
P50
P356
P1433
P1476
What happened after the clinic ...... mab in daily clinical practice
@en
P2093
Andreea N Boca
Luca Bianchi
Sergio Chimenti
P304
P356
10.1159/000365077
P577
2014-11-15T00:00:00Z